CD47 is expressed on the surface of all human solid tumor cells, and binding to SIRPα blockade of CD47 signaling using targeted monoclonal antibodies enabled macrophage phagocytosis of tumor cells that were otherwise protected in vitro [22]. The gene discussed is CD47; the disease is neoplasm.